Evidence map›Paper›PMID 20532967›Full record

ArticleJournal of clinical immunology2010

Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.

Paul Eggleton, Lorna W Harries, Giada Alberigo, Paul Wordsworth, Nick Viner, Richard Haigh, Suzanne Donnelly, Hugh W Jones, Ian C Chikanza, Thomas W E O'Conner and 2 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Increased autophagy in CD4European journal of immunology · 2016
    Article
  6. Article
  7. Isoflurane attenuates murine lupus nephritis by inhibiting NLRP3 inflammasome activation.International journal of clinical and experimental medicine · 2015
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Paul EggletonPeninsula Medical School, University of Exeter and Royal Devon and Exeter Hospital, Exeter, UK. paul.eggleton@pms.ac.uk
Lorna W Harries
Giada Alberigo
Paul Wordsworth
Nick Viner
Richard Haigh
Suzanne Donnelly
Hugh W Jones
Ian C Chikanza
Thomas W E O'Conner
Alasdair E R Thomson
Paul G Winyard
Royal Devon and Exeter Hospital · GBSt Thomas' Hospital · GBUniversity of Exeter · GBKingston Hospital · GBMater Misericordiae University Hospital · IENuffield Orthopaedic Centre · GBSt Bartholomew's Hospital · GBTorbay Hospital · GB

Funding

Arthritis Research UK 16537Arthritis Research UK 17231Arthritis Research UK E0521Arthritis Research UK E0543
6 · The paper itself

Abstract

introductionSystemic lupus erythematosus (SLE) and rheumatoid arthritis have complex genetic traits, but in both autoimmune diseases, dysfunctional apoptosis appears to play a part in disease pathology. This study examined the levels of in vitro apoptosis in lymphocytes from healthy, rheumatoid arthritis (RA) and SLE individuals and related observed differences to their lymphocyte apoptosis gene profiles. MATERIALS AND

methodsLymphocytes were assessed for cell death by nuclear pyknosis and DNA fragmentation. Control, SLE and RA apoptosis gene profiles were obtained by quantitative real-time polymerase chain reaction (QRT-PCR) analysis. RESULTS AND DISCUSSION: The mean levels of pyknosis in RA and SLE freshly isolated lymphocytes were significantly higher than in control lymphocytes. Ninety-three apoptosis genes were analysed by QRT-PCR of mRNA from RA, SLE and healthy lymphocytes. We identified significant differences (p < 0.05) in the expression of the same 11 of 93 and two of 93 apoptotic genes in individual SLE and RA patients tested as compared with controls.

conclusionWe propose that similarly altered expression of specific apoptotic regulatory genes (e.g., the death effector domain-containing DNA-binding protein and apoptosis-associated speck-like protein containing a CARD) occurs in the lymphocytes of individual patients with SLE or RA that may influence the extent and rate of spontaneous apoptosis in these autoimmune conditions.

Indexed as

ApoptosisAdultAgedArthritis, RheumatoidCARD Signaling Adaptor ProteinsCells, CulturedDeath Domain Receptor Signaling Adaptor ProteinsFemaleGene Expression ProfilingGene Expression RegulationHumansLupus Erythematosus, SystemicLymphocytesMaleMiddle AgedCARD Signaling Adaptor ProteinsDeath Domain Receptor Signaling Adaptor Proteins

Identifiers

PMID20532967
OpenAlexW2009394579

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.